BioSpace News Archive

Deals

Bristol-Myers Squibb Company Announces Launch of Private Offering of Senior Unsecured Notes

Bristol-Myers Squibb Company announced that, subject to market and other conditions, it intends to commence a private offering to sell senior unsecured notes.

May 1, 2019
·
4 min read
Hikma launches 100th injectable medicine in US with introduction of Vancomycin Hydrochloride for Injection, USP

Hikma Pharmaceuticals PLC launched its 100th injectable medicine in the United States with the introduction of Vancomycin Hydrochloride for Injection, USP, 5g, 10g and 750mg, through its US affiliate, Hikma Pharmaceuticals USA Inc.

May 1, 2019
·
9 min read
Biotech Beach

Quidel to Present at the Bank of America Merrill Lynch Health Care Conference 2019

Quidel Corporation announced that it will present at the Bank of America Merrill Lynch Health Care Conference 2019, to be held at the Encore at Wynn hotel in Las Vegas, Nevada on Thursday, May 16, 2019.

May 1, 2019
·
2 min read
Deals

Magenta Therapeutics Announces Pricing of Public Offering

Magenta Therapeutics, Inc. announced the pricing of its public offering of 4,250,000 shares of its common stock at a price to the public of $13.25 per share, for total gross proceeds of approximately $56.3 million.

May 1, 2019
·
3 min read
Business

CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy

CStone Pharmaceuticals and Numab Therapeutics AG announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a potential best-in-class monovalent, tri-specific antibody-based molecule targeting PD-L1, 4-1BB, and human serum albumin.

May 1, 2019
·
5 min read
Business

Perrigo Announces First Quarter Calendar Year 2019 Earnings Date And Upcoming Conference Participation

Perrigo Company plc announced that it will release its first quarter calendar year 2019 financial results on May 8, 2019 after market close in the U.S. and will discuss the results and 2019 guidance at its Investor Day on May 9, 2019.

May 1, 2019
·
4 min read
Business

ACADIA Pharmaceuticals Reports First Quarter 2019 Financial Results

1Q19 Net Sales Grew to $63.0 Million, a 29% Increase Over 1Q18

May 1, 2019
·
8 min read
Business

ICON Reports First Quarter 2019 Results

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2019.

May 1, 2019
·
6 min read
Manufacturing growth sees surging demand at CPhI South East Asia

SE Asian demand for manufacturing is being driven by recent regulatory changes and increased generics from Indonesia, Malaysia and the Philippines.

May 1, 2019
·
4 min read
Business

Nanobiotix announces first quarter 2019 revenue

NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – the “Company”), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announces its unaudited revenue for the first quarter of 2019.

May 1, 2019
·
4 min read